Return to homepagePandemic Pact

Galectin-3 as a prognostic biomarker of serious disease in patients positive to SARS-Cov-2

  • Funded by Consejo Nacional de Ciencia y Tecnología (CONACYT)
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Known Financial Commitments (USD)

    $0

  • Funder

    Consejo Nacional de Ciencia y Tecnología (CONACYT)

  • Research Location

    Mexico

  • Lead Research Institution

    Instituto Nacional de Ciencias Médicas Y Nutrición Salvador Zubirán

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Prognostic factors for disease severity

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract